CD317 (PDCA-1) Antibody, anti-mouse, REAfinity™
Synonyms: BST2, Bst-2, C87040, CD317, DAMP-1, GREG, mPDCA-1
RECOMBINANT EXTENDED VALIDATION
Bioz Star94/100 Bioz rating
5 Citations
Clone:
REA818 | JF05-1C2.4.1
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD317 (PDCA-1) Antibody, anti-mouse, REAfinity™

Flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 615
PE-Vio 770
PerCP-Vio 700
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-112-221, 130-112-378
Description:
Splenocytes of BALB/c mice were stained with CD317 (PDCA-1) antibodies or with the corresponding REA Control antibodies (left image) as well as with Anti-Ly-6C antibodies. Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence or 4',6-diamidino-2-phenylindole (DAPI) fluorescence, as in the case of tandem conjugates.

Application imageView details view details

Application imageView details view details
Extended validation for CD317 (PDCA-1) Antibody, anti-mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA818
129C1
low
927
low
44E9R (rIgG2a)
low
JF05-1C2.4.1
high

Cells were incubated with an excess of purified unconjugated CD317 (PDCA-1) (REA818) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for CD317 (PDCA-1) Antibody, anti-mouse, REAfinity™
Overview

Clone REA818 recognizes the mouse CD317 antigen, also known as mouse plasmacytoid dendritic cell antigen-1 (PDCA-1) or BST2. CD317 is specifically expressed on mouse PDCs, a subset of CD11c+ dendritic cells detected at low frequency in all lymphoid tissues, peripheral blood, and some non-lymphoid tissues. In mouse spleen, bone marrow, and lymph nodes, CD317 is exclusively expressed on cells which are CD11clow, Ly-6Chigh, CD45R (B220)+, MHC class IIlow, CD8alow/–, CD80low/–, CD86–, CD40–, CD11b–, CD90–, CD49b (DX5)–, CD3–, CD19–, i.e., on cells with the phenotype of mouse PDCs. Multi-color fluorescent staining of spleen cells clearly revealed that all CD11clow Ly-6Chigh CD45R (B220)+ PDCs are PDCA-1+ and that PDCA-1 expression is restricted to PDCs.

Additional information: Clone REA818 displays negligible binding to Fc receptors.

Alternative names

BST2, Bst-2, C87040, CD317, DAMP-1, GREG, mPDCA-1

Detailed product information

Technical specifications

Clone
REA818
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD317 (PDCA-1)
Molecular mass of antigen [kDa]
17
Distribution of antigen
dendritic cells
Entrez Gene ID
RRID
AB_2657409, AB_2657402, AB_2657407, AB_2657410, AB_2657398, AB_2657400, AB_2657401, AB_2657406, AB_2657404, AB_2657405, AB_2657403, AB_2657397, AB_2657395, AB_2657399, AB_2657396

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD317 (PDCA-1) Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support